MC. Tilinca, MC. Gliga and A. Varga (2022). The Pathophysiology and Management of Diabetic Ketoacidosis in COVID-19 Patients: a Literature Review. Journal of critical care medicine (Universitatea de Medicina si Farmacie din Targu-Mures), 8(1), 6-13. https://doi.org/10.2478/jccm-2021-0024

PubMed 35274050

[Abstract]
Diabetic individuals are considered a vulnerable population during the COVID-19 Pandemic, and several studies noted worse outcomes, including death, among those who get infected. Diabetic emergencies, such as ketoacidosis (DKA), are common and potentially life-threatening conditions in uncontrolled patients. While the pathophysiological background of the relationship between COVID-19 and DKA is not fully understood, early reports available so far indicate that patients with pre-existing diabetes who get infected with the SARS-CoV 2 virus are at higher risk of DKA. It was also suggested that DKA is a poor prognostic sign for infected patients, these being at higher risk of developing worse forms of COVID-19 disease and having high mortality. Therefore, healthcare personnel dealing with such patients face a considerable challenge, as the correct and safe emergency management of such cases is far from established. This article aimed to conduct a study that reviews the current published data available about patients with DKA and COVID-19.